Xiang Rong, Guan Xiao-Wen, Hui Ling, Jin Yong-Xin, Chen Shi-Wu
Department of Medicinal, Second Clinical Hospital of Northwest University for Nationalities & Second Provincial People's Hospital, Lanzhou 730000, PR China.
School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China.
Bioorg Med Chem Lett. 2017 Feb 15;27(4):713-717. doi: 10.1016/j.bmcl.2017.01.051. Epub 2017 Jan 17.
We have found that the deoxypodophyllotoxin-5-fluorouracil conjugate, 4'-O-demethyl-4-deoxyppodophyllotoxin-4'-yl 4-((6-(2-(5-fluorouracil-yl)acetamido) hexyl)amino)-4-oxobutanoate (C069), possessed superior cytotoxicities and less toxicity compared with etoposide. In this paper, the anti-angiogenic and vascular disrupting activities of C069 were examined with several in vitro and in vivo models. First, we demonstrated that C069 significantly inhibited the proliferation, migration, tube formation and disrupted the formed tube-like structures of HUVE cells, and inhibited angiogenesis in chicken chorioallantoic membrane assay. Furthermore, we found that C069 inhibited tube formation of HUVE cells by down-regulating the MMP-2, MMP-9, and phosphorylation of Akt and β-catenin. These results provided the initial evidence that C069 exerts potent anti-angiogenic and vascular disrupting effects.
我们发现,脱氧鬼臼毒素-5-氟尿嘧啶共轭物,4'-O-去甲基-4-脱氧鬼臼毒素-4'-基 4-((6-(2-(5-氟尿嘧啶基)乙酰氨基)己基)氨基)-4-氧代丁酸酯(C069),与依托泊苷相比具有更强的细胞毒性且毒性更小。在本文中,我们使用多种体外和体内模型检测了C069的抗血管生成和血管破坏活性。首先,我们证明C069显著抑制人脐静脉内皮细胞(HUVE细胞)的增殖、迁移、管腔形成并破坏已形成的管状结构,且在鸡胚绒毛尿囊膜试验中抑制血管生成。此外,我们发现C069通过下调基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)以及Akt和β-连环蛋白的磷酸化来抑制HUVE细胞的管腔形成。这些结果提供了初步证据,表明C069具有强大的抗血管生成和血管破坏作用。